Dobbs Ferry, NY, United States of America

Jonathan A Javitch

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • New York, NY (US) (2019)
  • New Rochelle, NY (US) (2018 - 2020)
  • Dobbs Ferry, NY (US) (2020 - 2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovations of Jonathan A. Javitch in Opioid Receptor Modulation

Introduction

Jonathan A. Javitch is a renowned inventor based in Dobbs Ferry, NY, known for his significant contributions to the field of pharmaceuticals, particularly in the area of opioid receptor modulators. With a total of 11 patents to his name, Javitch has played a pivotal role in developing compounds that offer new avenues for treating pain and mood disorders.

Latest Patents

Javitch’s latest innovations include two noteworthy patents. The first focuses on opioid receptor modulators providing a compound characterized by a complex structure, with various substitutions that enhance its pharmacological properties. This invention opens doors to novel treatments that can potentially address opioid addiction and deliver pain relief through alternative mechanisms.

The second patent involves Mitragynine alkaloids as opioid receptor modulators. This invention offers a method for treating individuals suffering from pain, depressive disorders, mood disorders, or anxiety disorders by administering a compound derived from Mitragynine. This approach has the potential to impact significantly the pharmaceutical landscape by providing alternatives to traditional opioid medications.

Career Highlights

Throughout his career, Jonathan A. Javitch has collaborated with distinguished institutions such as Columbia University and the Research Foundation for Mental Hygiene, Inc. His work primarily revolves around research and innovation in neuropharmacology, focusing on how receptor interactions can be harnessed to improve therapeutic options for patients.

Collaborations

Javitch's collaborative efforts extend to working alongside notable colleagues, including Andrew Carry Kruegel and Dalibor Sames. These partnerships have been instrumental in advancing research initiatives and fostering an environment conducive to innovative discoveries.

Conclusion

Jonathan A. Javitch’s contributions to the field of opioid receptor modulation reflect his dedication to pharmaceutical innovation. His patents not only illustrate his inventiveness but also highlight the potential for new treatments that could change the future of pain management and mental health care. Through his research and collaborations, Javitch continues to push the boundaries of scientific achievement, making a lasting impact in the realm of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…